Tanzini, Umberto
Rampi, Andrea
Vinciguerra, Alessandro
Danè, Giulia
Yacoub, Mona Rita
Bussi, Mario
Trimarchi, Matteo http://orcid.org/0000-0001-6472-3484
Funding for this research was provided by:
Università della Svizzera italiana
Article History
Received: 9 March 2024
Accepted: 12 May 2024
First Online: 8 June 2024
Declarations
:
: Informed consent was obtained from each patient for treatment and use of de-identified clinical data for study purposes; the study was approved by the institutional review board (IRB) of San Raffaele Hospital (Comitato Etico Ospedale San Raffaele, 112/INT/2021), and conducted according to the ethical standards established in the 1964 Declaration of Helsinki, as revised in 2013.
: MT declares honoraria as a speaker from Sanofi, Glaxo-Smith and Kline and Novartis. GD declares honoraria as a speaker from Sanofi, Glaxo-Smith and Kline. The other authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.